高级检索
当前位置: 首页 > 详情页

A Polymorphism at the microRNA Binding Site in the 3 ' Untranslated Region ofKRT81Is Associated with Breast Cancer

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Hebei Med Univ, Hosp 4, Dept Immunol & Rheumatol, 12 Jiankang Rd, Shijiazhuang 050011, Hebei, Peoples R China [2]Hebei Med Univ, Hosp 4, Dept Anim Ctr, Shijiazhuang, Hebei, Peoples R China [3]Hebei Med Univ, Hosp 4, Dept Breast Ctr, 12 Jiankang Rd, Shijiazhuang 050011, Hebei, Peoples R China
出处:
ISSN:

关键词: BC miR-SNP KRT81 rs3660

摘要:
Single nucleotide polymorphisms in miRNA binding sites (miR-SNPs) are associated with cancer risk. We assessed the relationship between five miR-SNPs in the 3 ' untranslated region (3 '-UTR) ofRYR3(rs1044129),KIAA0423(rs1053667),C14orf101(rs4901706),GOLGA7(rs11337), andKRT81(rs3660) and the risk of breast cancer (BC). The CC genotype of rs3660 located in the 3 '-UTR ofKRT81was identified for its association with lower BC risk (odds ratio, 0.093; 95% confidence interval, 0.045-0.193;p = 0.000). Immunnochemical analysis and Renilla luciferase reporter assays indicated that the CC genotype ofKRT81was associated with lower expression ofKRT81(p < 0.05). The subsequently functional analysis showed that knockdown theKRT81could inhibit proliferation and promote apoptosis of the MDA-MB-231 BC cells (p < 0.05) with monocyte chemotactic protein-1 (MCP-1) deregulation. Meanwhile,KRT81overexpression could promote the proliferation and inhibit the apoptosis of MCF-7 BC cells (p < 0.05). Our data demonstrated that theKRT81expressional change modulated by rs3660 miR-SNP could modify the carcinogenesis of BC, therebyKRT81would be a new target for BC treatment.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院分区:
出版当年[2020]版:
大类 | 3 区 生物
小类 | 3 区 生化与分子生物学 3 区 遗传学 4 区 细胞生物学
最新[2025]版:
大类 | 4 区 生物学
小类 | 4 区 生化与分子生物学 4 区 细胞生物学 4 区 遗传学
JCR分区:
出版当年[2020]版:
Q2 GENETICS & HEREDITY Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY Q3 CELL BIOLOGY
最新[2023]版:
Q2 GENETICS & HEREDITY Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY Q3 CELL BIOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2020版] 出版当年五年平均 出版前一年[2019版] 出版后一年[2021版]

第一作者:
第一作者机构: [1]Hebei Med Univ, Hosp 4, Dept Immunol & Rheumatol, 12 Jiankang Rd, Shijiazhuang 050011, Hebei, Peoples R China
通讯作者:
通讯机构: [1]Hebei Med Univ, Hosp 4, Dept Immunol & Rheumatol, 12 Jiankang Rd, Shijiazhuang 050011, Hebei, Peoples R China [3]Hebei Med Univ, Hosp 4, Dept Breast Ctr, 12 Jiankang Rd, Shijiazhuang 050011, Hebei, Peoples R China [*1]Department of Breast Center The Fourth Hospital of Hebei Medical University 12 Jiankang Road Shijiazhuang 050011 P.R. China [*2]Department of Immunology and Rheumatology The Fourth Hospital of Hebei Medical University 12 Jiankang Road Shijiazhuang 050011 P.R. China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:39770 今日访问量:0 总访问量:1333 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 河北医科大学第四医院 技术支持:重庆聚合科技有限公司 地址:河北省石家庄市健康路12号